Zolbetuximab is a new drug for treating advanced gastric cancer. The FDA is expected to make an approval decision in January 2024. Read on to learn more about zolbetuximab, how it works, its efficacy, its side effects, and who might benefit from the drug.
Stomach cancer is staged according to how far it has spread at the time of diagnosis. In stage 4, cancer has spread to other parts of the body, such as the liver, lungs, or lymph nodes. Stage 4 is also called advanced stomach cancer. Learn more about how it’s treated, and the five-year survival rate.